Differentiated Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Differentiated Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib
An ongoing prospective, non-interventional post-authorization safety study for patients with unresectable differentiated thyroid carcinoma t…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer [Phase 2]
This update describes a Phase 2 trial evaluating encorafenib and binimetinib, with or without nivolumab, for metastatic radioiodine-refracto…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Study of ACC-1898 in Adult Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study update for ACC-1898 in adults with advanced solid tumors; the trial is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial update reports results from CaboNivoIpi (cabozantinib, nivolumab, ipilimumab) in advanced differentiated thyroid cancer, inclu…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial evaluating dabrafenib with or without trametinib in advanced differentiated thyroid carcinoma, including follicular, papillary…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Clinical and Surgical Outcomes of Thyroid Carcinoma in Children and Adolescents
A completed clinical trial update reporting the clinical and surgical outcomes of pediatric and adolescent differentiated thyroid carcinoma,…
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) [Phase 2]
A Phase 2 trial evaluating the combination of lenvatinib and pembrolizumab in differentiated thyroid cancers has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial of lenvatinib with iodine therapy for radioactive iodine–sensitive differentiated thyroid cancer has terminated; results poste…
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: Clinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid Carcinoma [Phase 4]
Phase 4 clinical study evaluating the effect of selenium yeast capsules on prognosis in differentiated thyroid carcinoma, with an unclear st…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer [Phase 1, Phase 2]
Clinical trial update for cediranib maleate with or without lenalidomide in thyroid cancer completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma [Phase 2]
Phase 2 study of sulfatinib for advanced medullary thyroid carcinoma and iodine-refractory differentiated thyroid carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery [Phase 2]
This Phase 2 trial evaluated Sunitinib malate in iodine-refractory thyroid cancers, including differentiated and medullary subtypes. Results…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Compare the Aesthetic Effect of Different Thyroidectomies [NA]
This clinical trial compared the aesthetic outcomes of different thyroidectomy techniques in Differentiated Thyroid Carcinoma, and the study…
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Bioequivalence Study of Sorafenib Tablet and Nexavar [Phase 1]
A Phase 1 bioequivalence study comparing sorafenib tablet to Nexavar under fasting conditions has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: P53 in Differentiated Thyroid Cancer
This update reports a completed clinical trial investigating the role of p53 in differentiated thyroid carcinoma.
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer [Phase 2]
Phase 2 trial evaluating whether adding lithium carbonate to low-dose radioiodine therapy improves outcomes in early thyroid cancer.
-
CLINICAL_TRIALS trial_result · 2007-02-28Clinical Trial Update: OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation
This trial update indicates completion of a study evaluating the OnT4-Thyroglobulin assay used before rhTSH-aided radioiodine ablation in di…
-
CLINICAL_TRIALS trial_result · 2006-05-09Clinical Trial Update: Multicenter Study Differentiated Thyroid Carcinoma [Phase 3]
A multicenter Phase 3 trial in differentiated thyroid carcinoma, sponsored by University Hospital Muenster, has completed.